Amneal Pharmaceuticals (AMRX) Other Non-Current Assets (2017 - 2026)
Amneal Pharmaceuticals (AMRX) recorded Other Non-Current Assets of $80.67 million in Q2 2026, up 79.9% from $44.85 million a year earlier and up 47.0% from the prior quarter.
Powered by 
Analysis
Amneal Pharmaceuticals (AMRX) Other Non-Current Assets (2017 - 2026) Analysis & Trends
At the end of FY2025, Amneal Pharmaceuticals reported Other Non-Current Assets of $57.81 million, down 3.9% from FY2024.
- Annual Other Non-Current Assets has a five-year compound annual growth rate of 20.9% (FY2020 to FY2025).
- Across earlier years, Other Non-Current Assets came in at $60.13 million in FY2024 (+8.3%), $55.52 million in FY2023 (-46.2%), $103.22 million in FY2022 (+400.7%) and $20.61 million in FY2021 (-7.7%).
- The Q2 2026 figure is the highest quarterly Other Non-Current Assets since Q3 2023.
- On a year-over-year basis, Other Non-Current Assets rose in four of the last eight quarters, with an average decline of 3.2%.
- Peak year-over-year performance for Other Non-Current Assets in the last five years was growth of 454.4% in Q3 2022, against a decline of 59.3% in Q3 2024 at the low end.
- Per Business Quant, the preceding three quarters came in at $54.88 million (Q1 2026), $57.81 million (Q4 2025) and $39.46 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,157.21 Bn | 1,125.80 Bn | 19.71 Bn | 7.48 Bn |
| 2 | Johnson & Johnson | 624.79 Bn | 543.32 Bn | 17.26 Bn | 14.27 Bn |
| 3 | AbbVie | 511.04 Bn | 484.15 Bn | 12.70 Bn | 10.73 Bn |
| 4 | Merck | 365.98 Bn | 320.36 Bn | 12.21 Bn | 19.60 Bn |
| 5 | Novartis Ag | 296.82 Bn | 260.81 Bn | 11.24 Bn | 5.93 Bn |
| 6 | Astrazeneca | 260.38 Bn | 234.06 Bn | 12.86 Bn | - |
| 7 | Amgen | 234.75 Bn | 190.15 Bn | 7.24 Bn | 12.98 Bn |
| 8 | Gilead Sciences | 193.87 Bn | 168.07 Bn | 6.22 Bn | 4.75 Bn |
| 9 | Pfizer | 171.45 Bn | 118.10 Bn | 10.94 Bn | 9.94 Bn |
| 10 | Amneal Pharmaceuticals | 6.31 Bn | 5.51 Bn | 334.51 Mn | 80.67 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 80.67 Mn |
| Mar 31, 2026 | 54.88 Mn |
| Dec 31, 2025 | 57.81 Mn |
| Sep 30, 2025 | 39.46 Mn |
| Jun 30, 2025 | 44.85 Mn |
| Mar 31, 2025 | 45.42 Mn |
| Dec 31, 2024 | 60.13 Mn |
| Sep 30, 2024 | 36.27 Mn |
| Jun 30, 2024 | 77.03 Mn |
| Mar 31, 2024 | 73.75 Mn |
| Dec 31, 2023 | 55.52 Mn |
| Sep 30, 2023 | 89.04 Mn |
| Jun 30, 2023 | 93.24 Mn |
| Mar 31, 2023 | 86.43 Mn |
| Dec 31, 2022 | 103.22 Mn |
| Sep 30, 2022 | 108.26 Mn |
| Jun 30, 2022 | 79.84 Mn |
| Mar 31, 2022 | 63.94 Mn |
| Dec 31, 2021 | 20.61 Mn |
| Sep 30, 2021 | 19.53 Mn |
API Access
Amneal Pharmaceuticals Other Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-non-current-assets&ticker=AMRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-non-current-assets", "ticker": "AMRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-non-current-assets&ticker=AMRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();